Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Markets expect ...

There are instances where high-yielding stocks can simply be great deals. Three stocks that pay at least 6% and don't look ...

So, is Pfizer's 7.63% dividend yield worth the effort? If I base my decision solely on a first level analysis of its past, I would say NO. Yet, investment is always about the future, not the past ...

But I wouldn't bet on the drugmaker's dividend yield remaining as high as it is now. A lot of negativity is baked into Pfizer's share price, with the stock trading at less than 8 times forward ...

Consider pharmaceutical giant Pfizer (NYSE: PFE). Its dividend yield is around 7.5% right now ... Where to invest $1,000 right now? Our analyst team just revealed what they believe are the ...

A high dividend yield can be enticing, but it can also raise flags for income investors. Pfizer's falling valuation has pushed its yield up to well over 7%, which warrants a closer look.

Triumph Capital Management increased its Pfizer stake by 20%, holding over 10,000 shares worth $273,000. Several other firms ...

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying ...